EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention - 07/08/11
, Marco Miano, MD a, Glauco Cincotta, MD a, Anna Caggegi, MD a, Cettina Ruperto, MD a, Rita Bucalo, MD a, Alessandra Sanfilippo, MD a, Piera Capranzano, MD a, Corrado Tamburino, MD, PhD, FESC, FSCAI a, bRiassunto |
Background |
Whether SYNTAX score should be used as a stand-alone tool or whether its performance may be improved by the parallel use of clinical scores focusing on comorbidities, such as EuroSCORE, is a matter of debate.
Methods |
A combined risk model including both clinical and angiographic information was developed, and its performance tested on a contemporary population of 255 patients with left main disease undergoing percutaneous coronary intervention (PCI). A global risk classification (GRC) system was created by combination of SYNTAX score and EuroSCORE strata, and new classes of risk were defined.
Results |
When EuroSCORE was fitted into the SYNTAX score model, c-statistic increased from 0.681 to 0.732 for the prediction of cardiac mortality. The likelihood ratio test for the significance of adding the EuroSCORE term to the model was χ2 = 4.109 (P = .043) with a net reclassification improvement of 26% (P = .002). GRC showed the best prediction and discriminative ability in terms of two-year cardiac mortality (HR 3.40, 95% CI 1.79-6.43, P < .001; c-statistic 0.756) as compared with SYNTAX score (HR 2.87, 95% CI 1.35-6.10, P = .006; c-statistic 0.747) and EuroSCORE (HR 3.04, 95% CI 1.41-6.57, P = .005; c-statistic 0.708) alone.
Conclusions |
We found a significant improvement in the prediction of cardiac mortality with the inclusion of EuroSCORE in a SYNTAX score-based model. The degree of reclassification between treatment threshold categories indicates that clinical and angiographic information are both important for assessing individual risk of patients undergoing left main PCI.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 159 - N° 1
P. 103-109 - Gennaio 2010 Ritorno al numero
Articolo precedente
- Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: Do we really need it?
- Valeria Calvi, Daniela Dugo, Davide Capodanno, Rocco Arancio, Angelo Di Grazia, Claudio Liotta, Euglena Puzzangara, Antonio Ragusa, Alberto Arestia, Corrado Tamburino
- Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial
- Harvey D. White, Philip E. Aylward, Richard Gallo, Christoph Bode, Gabriel Steg, Steven R. Steinhubl, Gilles Montalescot, for the STEEPLE Investigators
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?